Acylated derivatives of etoposide

Details Acylated derivatives of etoposide Acylated derivatives of etoposide

1989-06-07

1991-07-30

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 41, 536 181, 536 171, A61K 3170, C07H 1500

Patent

active

050360558

ABSTRACT:
The epipodophyllotoxin glucosides disclosed are acylated at herein one or both sugar hydroxyl groups. These compounds exhibit significant activity against P388 murine leukemia.

REFERENCES:
patent: 3524844 (1970-08-01), Keller-Juslen
patent: 4564675 (1986-01-01), Kurabayashi et al.
patent: 4567253 (1986-01-01), Durst et al.
patent: 4716221 (1987-12-01), Umezawa et al.
patent: 4853467 (1989-08-01), Vyas et al.
patent: 4868291 (1989-09-01), Saulnier et al.
patent: 4874851 (1989-10-01), Vyas et al.
patent: 4888419 (1989-12-01), Saulnier et al.
patent: 4912204 (1990-03-01), Ohnuma et al.
patent: 4916217 (1990-04-01), Saulnier et al.
Yamashita, K., et al., "Measurement of Plasma Etoposide by Radio Immunoassay", Journal of Pharm. & Biomed. Anal., 5(1):11-20.

Affiliated with

Also associated with

Rating

Acylated derivatives of etoposide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acylated derivatives of etoposide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated derivatives of etoposide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1542698